le Roux CW - Search Results

1

Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial.

Risstad H, Kristinsson JA, Fagerland MW, le Roux CW, Birkeland KI, Gulseth HL, Thorsby PM, Vincent RP, Engström M, Olbers T, Mala T. Risstad H, et al. Among authors: le roux cw. Surg Obes Relat Dis. 2017 Sep;13(9):1544-1553. doi: 10.1016/j.soard.2017.05.024. Epub 2017 May 25. Surg Obes Relat Dis. 2017. PMID: 28756050 Clinical Trial.

2

Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects.

le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR. le Roux CW, et al. J Clin Endocrinol Metab. 2005 Feb;90(2):1068-71. doi: 10.1210/jc.2004-1216. Epub 2004 Nov 2. J Clin Endocrinol Metab. 2005. PMID: 15522935

3

New agents in development for the management of obesity.

Vincent RP, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Int J Clin Pract. 2007 Dec;61(12):2103-12. doi: 10.1111/j.1742-1241.2007.01558.x. Epub 2007 Sep 10. Int J Clin Pract. 2007. PMID: 17850307 Free article. Review.

4

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T. le Roux CW, et al. Ann Surg. 2007 Nov;246(5):780-5. doi: 10.1097/SLA.0b013e3180caa3e3. Ann Surg. 2007. PMID: 17968169 Clinical Trial.

5

Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels.

Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Borg CM, et al. Among authors: le roux cw. Obes Surg. 2007 Sep;17(9):1193-8. doi: 10.1007/s11695-007-9211-2. Obes Surg. 2007. PMID: 18074494

6

Changes in gut hormones after bariatric surgery.

Vincent RP, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Clin Endocrinol (Oxf). 2008 Aug;69(2):173-9. doi: 10.1111/j.1365-2265.2007.03164.x. Epub 2007 Dec 20. Clin Endocrinol (Oxf). 2008. PMID: 18167136 Review.

7

Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake.

le Roux CW, Borg CM, Murphy KG, Vincent RP, Ghatei MA, Bloom SR. le Roux CW, et al. Ann Clin Biochem. 2008 Jan;45(Pt 1):93-5. doi: 10.1258/acb.2007.007068. Ann Clin Biochem. 2008. PMID: 18275682

8

Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.

Vincent RP, Ashrafian H, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Nat Clin Pract Gastroenterol Hepatol. 2008 May;5(5):268-77. doi: 10.1038/ncpgasthep1118. Epub 2008 Apr 1. Nat Clin Pract Gastroenterol Hepatol. 2008. PMID: 18382432 Review.

9

The satiety hormone peptide YY as a regulator of appetite.

Vincent RP, le Roux CW. Vincent RP, et al. Among authors: le roux cw. J Clin Pathol. 2008 May;61(5):548-52. doi: 10.1136/jcp.2007.048488. J Clin Pathol. 2008. PMID: 18441153 Review.

10

When the brakes came off: re-feeding oedema after deflation of a gastric band: a case report.

Vincent RP, Aylwin SJ, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Obes Surg. 2009 Oct;19(10):1468-70. doi: 10.1007/s11695-009-9935-2. Epub 2009 Aug 13. Obes Surg. 2009. PMID: 19680731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page